Clinical Trial Update: Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia [NA]

View source ↗

Summary

A clinical trial comparing procalcitonin and C-reactive protein to guide therapy in community-acquired pneumonia was withdrawn. No results were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Community-acquired Pneumonia

Snippet

Sponsor: Federal University of Minas Gerais | Conditions: Community-acquired Pneumonia | NA | Status: WITHDRAWN